O-tert.Butyl-L-tyrosine is a protected tyrosine derivative in which the phenolic hydroxyl side chain is converted to an O-tert-butyl ether while retaining the amino acid backbone, bearing both an amino group and a carboxyl group. The molecule therefore features a substituted aromatic ring with an O-tert-butyl protecting group that masks the phenolic functionality, and it is specified as the L stereochemical form at the alpha carbon. In peptide and amino acid derivative synthesis, this protection pattern supports chemoselective handling of the tyrosine side chain during coupling and subsequent deprotection steps, and it can be used to prepare labeled or structurally defined tyrosine-containing peptide intermediates for chemical biology and structural studies.
CAT No: CP02141
CAS No:18822-59-8
Synonyms/Alias:H-Tyr(tBu)-OH;18822-59-8;O-tert-Butyl-L-tyrosine;(S)-2-Amino-3-(4-(tert-butoxy)phenyl)propanoicacid;SBB063921;(2S)-2-amino-3-[4-(tert-butoxy)phenyl]propanoicacid;O-t-Butyl-L-tyrosine;PubChem19065;AC1OLQP8;O-tert-ButylL-tyrosine;O-tert.Butyl-L-tyrosine;533130_ALDRICH;SCHEMBL1258519;CTK3J1775;MolPort-003-936-064;SNZIFNXFAFKRKT-NSHDSACASA-N;ACT10066;ZINC4899430;ANW-23387;CH-179;MFCD00037202;RW2355;AKOS015889737;AM82345;RTR-036007
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.